These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17191058)

  • 41. [Use of aerosol preparations in external therapy of patients with eczema].
    Somov BA; Ivanov VV
    Vestn Dermatol Venerol; 1974 Oct; 0(10):52-4. PubMed ID: 4432617
    [No Abstract]   [Full Text] [Related]  

  • 42. Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy.
    Cook BA; Warshaw EM
    Am J Clin Dermatol; 2009; 10(2):103-18. PubMed ID: 19222250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two cases of Zoon's balanitis treated with pimecrolimus 1% cream.
    Bardazzi F; Antonucci A; Savoia F; Balestri R
    Int J Dermatol; 2008 Feb; 47(2):198-201. PubMed ID: 18211499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study.
    Volz T; Caroli U; Lüdtke H; Bräutigam M; Kohler-Späth H; Röcken M; Biedermann T
    Br J Dermatol; 2008 Sep; 159(4):936-41. PubMed ID: 18647310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of cutaneous lupus with Elidel.
    Zabawski E
    Dermatol Online J; 2002 Oct; 8(2):25. PubMed ID: 12546779
    [No Abstract]   [Full Text] [Related]  

  • 46. Topical pimecrolimus: a new horizon for vitiligo treatment?
    Sendur N; Karaman G; Saniç N; Savk E
    J Dermatolog Treat; 2006; 17(6):338-42. PubMed ID: 17853306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis.
    Schwarz T; Kreiselmaier I; Bieber T; Thaci D; Simon JC; Meurer M; Werfel T; Zuberbier T; Luger TA; Wollenberg A; Bräutigam M
    J Am Acad Dermatol; 2008 Jul; 59(1):34-40. PubMed ID: 18462835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
    Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T
    Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
    Fleischer AB; Abramovits W; Breneman D; Jaracz E;
    J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a > 2000 patient study.
    Ring J; Abraham A; de Cuyper C; Kim K; Langeland T; Parra V; Pigatto P; Reunala T; Szczepanski R; Möhrenschlager M; Bräutigam M; Rossi AB; Meents-Kopecky E; Schneider D
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):195-203. PubMed ID: 18211413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1 year.
    Van Leent EJ; De Vries HJ; Ebelin ME; Burtin P; Scott G; Bos JD
    J Dermatolog Treat; 2007; 18(1):19-22. PubMed ID: 17365262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
    Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
    Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis.
    Sigurgeirsson B; Ho V; Ferrándiz C; Andriano K; Grinienko A; Jimenez P;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1290-301. PubMed ID: 18624866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial.
    Weissenbacher S; Merkl J; Hildebrandt B; Wollenberg A; Braeutigam M; Ring J; Hofmann H
    Br J Dermatol; 2007 Apr; 156(4):728-32. PubMed ID: 17493072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
    Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
    Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two therapeutic challenges: facial vitiligo successfully treated with 1% pimecrolimus cream and 0.005% calcipotriol cream.
    Bilaç DB; Ermertcan AT; Sahin MT; Oztürkcan S
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):72-3. PubMed ID: 18355205
    [No Abstract]   [Full Text] [Related]  

  • 57. Facial flush reaction after alcohol ingestion during topical pimecrolimus and tacrolimus treatment.
    Stinco G; Piccirillo F; Sallustio M; Patrone P
    Dermatology; 2009; 218(1):71-2. PubMed ID: 18832812
    [No Abstract]   [Full Text] [Related]  

  • 58. Oral tazarotene and oral pimecrolimus: novel oral therapies in development for psoriasis.
    Singh F; Weinberg JM
    J Drugs Dermatol; 2004; 3(2):141-3. PubMed ID: 15098968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dyshidrosiform pemphigoid: report of a case.
    Sugimura C; Katsuura J; Moriue T; Matsuoka Y; Kubota Y
    J Dermatol; 2003 Jul; 30(7):525-9. PubMed ID: 12928541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
    Langley RG; Eichenfield LF; Lucky AW; Boguniewicz M; Barbier N; Cherill R
    Pediatr Dermatol; 2008; 25(3):301-7. PubMed ID: 18577032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.